Press Room

News / Jun 02, 2021

Have your say and cast your vote for Guy Villax

EY World Entrepreneur Of The Year™ 2021 is the world's most prestigious business award for entrepreneurs

Guy Villax - EY World Entrepreneur Of The Year™ 2021 | Hovione

We are in countdown to the election of EY World Entrepreneur Of The Year™ 2021, the world's most prestigious business award for entrepreneurs and Guy Villax, CEO of Hovione, is a candidate. 

Vote and support Guy Villax, as no Portuguese has ever won this global award.

Guy Villax, CEO of Hovione, won the Portuguese election and is one of 38 candidates who, on June 10 – a special day in Portugal as we celebrate the Day of Portugal across all the Portuguese communities around the globe – can be chosen by the jury and supported by anyone who wants to participate in the open voting.

Vote and support Hovione. Support Guy Villax.

Saving lives is the driving force behind family pharma business Hovione.

 

Cast your vote here

 

Learn more about this award

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025